Urologix Price Prediction

ULGXDelisted Stock  USD 0.0001  0.00  0.00%   
At this time the relative strength index (rsi) of Urologix's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Urologix's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Urologix, which may create opportunities for some arbitrage if properly timed.
Using Urologix hype-based prediction, you can estimate the value of Urologix from the perspective of Urologix response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Urologix to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Urologix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Urologix after-hype prediction price

    
  USD 1.0E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Intrinsic
Valuation
LowRealHigh
0.000.0000850.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Urologix. Your research has to be compared to or analyzed against Urologix's peers to derive any actionable benefits. When done correctly, Urologix's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Urologix.

Urologix After-Hype Price Prediction Density Analysis

As far as predicting the price of Urologix at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Urologix or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Urologix, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Urologix Estimiated After-Hype Price Volatility

In the context of predicting Urologix's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Urologix's historical news coverage. Urologix's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Urologix's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.0001
After-hype Price
0.00
Upside
Urologix is very steady at this time. Analysis and calculation of next after-hype price of Urologix is based on 3 months time horizon.

Urologix Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Urologix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Urologix backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Urologix, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
3 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.0001
0.00 
0.00  
Notes

Urologix Hype Timeline

Urologix is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Urologix is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Urologix is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.22. Urologix had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be any time.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Urologix Related Hype Analysis

Having access to credible news sources related to Urologix's direct competition is more important than ever and may enhance your ability to predict Urologix's future price movements. Getting to know how Urologix's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Urologix may potentially react to the hype associated with one of its peers.

Urologix Additional Predictive Modules

Most predictive techniques to examine Urologix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Urologix using various technical indicators. When you analyze Urologix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Urologix Predictive Indicators

The successful prediction of Urologix stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Urologix, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Urologix based on analysis of Urologix hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Urologix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Urologix's related companies.

Story Coverage note for Urologix

The number of cover stories for Urologix depends on current market conditions and Urologix's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Urologix is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Urologix's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Urologix Pink Sheet

If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years